Drug Farm's First-in-Class Drug DF-006 Receives IND Approval for Phase 1b Trial in Chronic Hepatitis B, Supported by Yidu Tech

Yesterday, Drug Farm announced that its developed drugDF-006Has obtained the Center for Drug Evaluation in China(CDE)Approval for Chronic Hepatitis B(HBV)Conducted among patients1bClinical trial phase. As a key service support provider for the project, Yidu Tech relies on its deep regulatory expertise, medical knowledge, and efficient project execution capabilities.Provided high-quality registration services for this project, contributing to the successful approval of its clinical trial application.Lays a solid foundation for subsequent clinical progress and in-depth cooperation between the two parties.

Relevant data shows that China has approximately7500Ten ThousandChronic hepatitis B virus carriers, but the diagnosis rate and treatment rate are only22%And15%, there is still significant room for improvement.

DF-006Is an oralALPK1Agonist immunomodulators, which can effectively stimulate local innate immunity in the liver. The drug has successfully completed single and multiple dose escalation studies in healthy volunteers.(MAD)Evaluation, as well as in virological suppressionHBeAgNegative Chronic Hepatitis B(CHB)Multiple dose escalation assessments in patients. After obtaining clinical trial approval for the new drug in China,DF-006Globally6Countries have been approved to conduct clinical trials.

InDF-006In the process of applying for clinical trials in China, Yidu Tech fully leveraged its professional advantages in registration services to provide support for the project.Full-process Support: Through in-depth interpretationCDEThe latest review requirements, combined with early trial data, have established a clear chain of evidence and registration logic. On this basis, through efficient project management and interdisciplinary collaboration, the team systematically integrates professional resources in medicine, regulations, etc., accurately responds to review communication needs, provides key data presentation and solutions, ultimately contributing to the success.DF-006Efficiently passing the review demonstrates its professional value in providing full-process services in the field of innovative drug registration.

With "AI"Medical Brain"YiduCoreWith the underlying data intelligence capabilities, Yidu Tech has built a full life cycle solution for drug research and development, serving over350Pharmaceutical companies in and out of China have accumulated686Clinical trial project experience, real-world research projects served275Item.

This assistanceDF-006Receiving clinical trial approval is bothA Milestone in the Collaboration Between Yidu Tech and Drug Farm, also bringing new treatment expectations for patients with chronic hepatitis B. With 1b The initiation of the clinical research phase, Yidu Tech will continue to closely collaborate with Drug Farm, facilitating the smooth progress of the project. In the future, Yidu Tech will also fully leverage its own strengths to deepen cooperation with more innovative pharmaceutical companies like Drug Farm.Jointly Accelerate the Development Process of Innovative Source Drugs, bringing new hope to patients worldwide.

About Drug Farm

Drug Farm is a company dedicated to developing original new drugs.(first-in-class)A biotech innovation company focused on targeting innate immunity in cardiovascular diseases, blood cancers,ROSAHSyndrome (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache), innovative therapies in disease areas such as hepatitis B.

About Yidu Tech

As ChinaAIMedical Change Driver, Yidu Technology (2158.HK) Adhering to the mission of "making precision medicine accessible to everyone," we create professional, efficient, precise, and inclusive medical artificial intelligence products and solutions. Based on the company's self-developed core algorithm engineYiduCore, Yidu Tech builds“Data-Algorithm-Scene”Flywheel Closed Loop, AchievedAIThe high-efficiency innovation and low-cost scaled application of technology drive the empowerment of intelligent decision-making.“Med-Drug-Risk-Patient”Full industrial chain ecosystem.

In the life sciences field, Yidu Tech provides data-driven clinical development, real-world research, and commercialization solutions for global pharmaceutical and medical device companies, helping clients improve R&D efficiency, optimize product launch pathways, and reduce innovation costs.